Discontinued — last reported Q4 '20
Dollar General Business Sale Proceeds decreased by 13.3% to $716.00K in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 50.1%, from $1.43M to $716.00K. Over 4 years (FY 2021 to FY 2025), Business Sale Proceeds shows a downward trend with a -5.2% CAGR.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
proceeds_from_sale_of_business| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $807.00K | $998.00K | $2.16M | $935.00K | $736.00K | $1.43M | $222.00K | $2.85M | $1.54M | $1.70M | $1.73M | $1.24M | $814.00K | $711.00K | $602.00K | $1.43M | $552.00K | $1.87M | $826.00K | $716.00K |
| QoQ Change | — | +23.7% | +116.7% | -56.8% | -21.3% | +94.3% | -84.5% | >999% | -46.0% | +10.1% | +2.0% | -28.5% | -34.1% | -12.7% | -15.3% | +138.2% | -61.5% | +239.1% | -55.9% | -13.3% |
| YoY Change | — | — | — | — | -8.8% | +43.3% | -89.7% | +204.6% | +109.1% | +18.5% | +678.8% | -56.6% | -47.1% | -58.1% | -65.2% | +16.0% | -32.2% | +163.3% | +37.2% | -50.1% |